NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/07/2026
Back to search
Official data from USPTO
CHONGKUNDANG HEALTHCARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
CHONGKUNDANG HEALTHCARE
ST13
US500000099090756Class
5
Filing
99090756
Registration
8330786
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
07/07/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
03/18/2025
Registration date
07/07/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/07/2026
Last transaction
07/07/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Seoul, KR
Examiner
SCHNELL, BENJAMIN L
Law office
O90
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Chong Kun Dang Holdings Corp.
Representatives
Miriam D. Trudell Davis Graham & Stubbs LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Baby foods; Lactose for medical purposes; Dietary supplements for human consumption; Dietary and nutritional supplements for medical purpose; Health food supplements; Nutraceuticals for use as a dietary supplement; Nutraceuticals for the treatment of cancerdiabeteskidney diseaseshypercholesteremiahyperlipidemiaeye diseases and conditionsskin disordershypertensioninfectious diseasesgoutbone fracturesallergic rhinitis and asthmaautoimmune diseases; Pharmaceutical preparations for the treatment and prevention of cancerdiabeteskidney diseaseshypercholesteremiahyperlipidemiaeye diseases and conditionsskin disordershypertensioninfectious diseasesgoutbone fracturesallergic rhinitis and asthmaautoimmune diseases; Vitamin supplements; Medical preparations for slimming purposes; Probiotic preparations for medical use; Lutein dietary supplements
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/07/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/19/2026
PUBO
PUBLISHED FOR OPPOSITION
05/19/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/13/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/22/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/06/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/06/2026
ALIE
ASSIGNED TO LIE
04/02/2026
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/30/2026
DOCK
ASSIGNED TO EXAMINER
02/27/2026
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/04/2025
GNSL
LETTER OF SUSPENSION E-MAILED
09/04/2025
CNSL
SUSPENSION LETTER WRITTEN
09/04/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
08/29/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/29/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
08/29/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/29/2025
DOCK
ASSIGNED TO EXAMINER
08/18/2025
MAFR
APPLICATION FILING RECEIPT MAILED
03/18/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/18/2025
NWAP
NEW APPLICATION ENTERED
03/18/2025
Continuous trademark protection
Get notified about every new filing that threatens CHONGKUNDANG HEALTHCARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.